| Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus TAS Halden, KE Kvitne, K Midtvedt, L Rajakumar, I Robertsen, J Brox, ... Diabetes care 42 (6), 1067-1074, 2019 | 158 | 2019 |
| The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review PC Angeles, I Robertsen, LT Seeberg, V Krogstad, J Skattebu, R Sandbu, ... Obesity reviews 20 (9), 1299-1311, 2019 | 66 | 2019 |
| Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed I Robertsen, A Åsberg, AO Ingerø, NT Vethe, S Bremer, S Bergan, ... Transplantation 99 (3), 528-532, 2015 | 66 | 2015 |
| High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation EJ Egeland, I Robertsen, M Hermann, K Midtvedt, E Størset, ... Transplantation 101 (8), e273-e279, 2017 | 52 | 2017 |
| Correlation of body weight and composition with hepatic activities of cytochrome P450 enzymes V Krogstad, A Peric, I Robertsen, MK Kringen, M Vistnes, J Hjelmesæth, ... Journal of Pharmaceutical Sciences 110 (1), 432-437, 2021 | 38 | 2021 |
| A comparative analysis of cytochrome P450 activities in paired liver and small intestinal samples from patients with obesity V Krogstad, A Peric, I Robertsen, MK Kringen, C Wegler, PC Angeles, ... Drug Metabolism and Disposition 48 (1), 8-17, 2020 | 31 | 2020 |
| Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical toxicology … F Lemaitre, NT Vethe, A d'Avolio, C Tron, I Robertsen, B De Winter, ... Therapeutic drug monitoring 42 (5), 665-670, 2020 | 27 | 2020 |
| Tacrolimus area under the concentration versus time curve monitoring, using home-based volumetric absorptive capillary microsampling MT Gustavsen, K Midtvedt, NT Vethe, I Robertsen, S Bergan, A Åsberg Therapeutic Drug Monitoring 42 (3), 407-414, 2020 | 26 | 2020 |
| High tacrolimus clearance–a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single‐center cohort study EJ Egeland, AV Reisæter, I Robertsen, K Midtvedt, EH Strøm, H Holdaas, ... Transplant International 32 (3), 257-269, 2019 | 26 | 2019 |
| Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised … J Hjelmesæth, A Åsberg, S Andersson, R Sandbu, I Robertsen, ... BMJ open 8 (5), e021878, 2018 | 21 | 2018 |
| More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients I Robertsen, A Åsberg, T Granseth, NT Vethe, F Akhlaghi, M Ghareeb, ... Transplantation 97 (12), 1266-1271, 2014 | 21 | 2014 |
| Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients MT Gustavsen, K Midtvedt, I Robertsen, JB Woillard, J Debord, ... Clinical and translational science 13 (6), 1327-1335, 2020 | 19 | 2020 |
| Measured GFR by utilizing population pharmacokinetic methods to determine iohexol clearance A Åsberg, A Bjerre, R Almaas, S Luis-Lima, I Robertsen, CL Salvador, ... Kidney International Reports 5 (2), 189-198, 2020 | 19 | 2020 |
| Drug disposition protein quantification in matched human jejunum and liver from donors with obesity C Wegler, JR Wiśniewski, I Robertsen, H Christensen, J Kristoffer Hertel, ... Clinical Pharmacology & Therapeutics 111 (5), 1142-1154, 2022 | 18 | 2022 |
| Proteomics‐informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight C Wegler, L Prieto Garcia, S Klinting, I Robertsen, JR Wiśniewski, ... Clinical Pharmacology & Therapeutics 109 (3), 762-771, 2021 | 18 | 2021 |
| A limited sampling strategy to estimate exposure of everolimus in whole blood and peripheral blood mononuclear cells in renal transplant recipients using population … I Robertsen, J Debord, A Åsberg, P Marquet, JB Woillard Clinical Pharmacokinetics 57, 1459-1469, 2018 | 17 | 2018 |
| Closer to the site of action: everolimus concentrations in peripheral blood mononuclear cells correlate well with whole blood concentrations I Robertsen, NT Vethe, K Midtvedt, P Falck, H Christensen, A Åsberg Therapeutic Drug Monitoring 37 (5), 675-680, 2015 | 15 | 2015 |
| Short‐and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity–a non‐randomized three‐armed controlled trial KE Kvitne, I Robertsen, E Skovlund, H Christensen, V Krogstad, C Wegler, ... Clinical and Translational Science 15 (1), 221-233, 2022 | 14 | 2022 |
| Determination of tacrolimus concentration and protein expression of P-glycoprotein in single human renal core biopsies V Krogstad, NT Vethe, I Robertsen, G Hasvold, AMD Ose, M Hermann, ... Therapeutic Drug Monitoring 40 (3), 292-300, 2018 | 14 | 2018 |
| Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients I Robertsen, P Falck, AK Andreassen, NK Næss, N Lunder, H Christensen, ... Transplantation research 2, 1-8, 2013 | 14 | 2013 |
